Average Co-Inventor Count = 10.06
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Nurix Therapeutics, Inc. (8 from 14 patents)
8 patents:
1. 12234230 - Substituted benzyl-triazole compounds for Cbl-b inhibition, and further uses thereof
2. 12049471 - Cyano cyclobutyl compounds for Cbl-b inhibition and uses thereof
3. 11951133 - 3-substituted piperidine compounds for Cbl-b inhibition, and use thereof
4. 11866442 - Bifunctional compounds for degrading BTK via ubiquitin proteosome pathway
5. 11530229 - Cyano cyclobutyl compounds for CBL-B inhibition and uses thereof
6. 11479556 - Bifunctional compounds for degrading BTK via ubiquitin proteosome pathway
7. 11464802 - 3-substituted piperidine compounds for Cbl-b inhibition, and use thereof
8. 11401267 - Substituted benzyl-triazole compounds for Cbl-b inhibition, and further uses thereof